Because it has been reported that SUMO-1 promotes glycolysis in tumor cells (22), we investigated whether SAE1/UBA2-mediated SUMOylation is involved in regulating glycolytic metabolism in RA FLSs. Here, SUMO1 is linked to neoplasm.